Dynamics and distribution of Klothoβ (KLB) and Fibroblast Growth Factor Receptor-1 (FGFR1) in living cells reveal the Fibroblast Growth Factor-21 (FGF21)-induced receptor complex

Journal of Biological Chemistry

Volumn 287, Issue 24, 2012, Pages 19997-20006

  Ming, Aaron Y K ^a,c   Yoo, Eunjong ^a   Vorontsov, Eugene N ^a,c   Altamentova, Svetlana M ^c   Kilkenny, Dawn M ^a   Rocheleau, Jonathan V ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATE SIZE; CO-EXPRESSION; CO-IMMUNOPRECIPITATIONS; FIBROBLAST GROWTH; FIBROBLAST GROWTH FACTOR; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; LIVING CELL; RECEPTOR COMPLEX; SIGNALING COMPLEX;

CELL MEMBRANES; DIMERS; DYNAMICS; FLUORESCENCE; LUMINANCE; PHOTOBLEACHING; SUGARS;

MOLECULAR BIOLOGY;

FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1C; GALECTIN; GALECTIN 3; KLOTHO BETA PROTEIN; KLOTHO PROTEIN; LACTOSE; UNCLASSIFIED DRUG;

ARTICLE; BLEACHING; CELL MEMBRANE; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MEMBRANE TRANSPORT; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; FIBROBLAST GROWTH FACTORS; GALECTIN 3; HEK293 CELLS; HELA CELLS; HUMANS; MEMBRANE PROTEINS; MICE; MULTIPROTEIN COMPLEXES; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SIGNAL TRANSDUCTION;

EID: 84862017269     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.325670     Document Type: Article

References (39)

1. Itoh, N., and Ornitz, D. M. (2004) Evolution of the Fgf and Fgfr gene families. Trends Genet. 20, 563-569 (Pubitemid 39314564)
2. Ornitz, D. M., and Itoh, N. (2001) Fibroblast growth factors. Genome Biol. 2, REVIEWS3005
3. Johnson, D. E., and Williams, L. T. (1993) Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60, 1-41
4. Kharitonenkov, A. (2009) FGFs and metabolism. Curr. Opin. Pharmacol. 9, 805-810
5. Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., and Maratos-Flier, E. (2007) Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5, 426-437 (Pubitemid 46825495)
6. Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., Elmquist, J. K., Gerard, R. D., Burgess, S. C., Hammer, R. E., Mangelsdorf, D. J., and Kliewer, S. A. (2007) Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415-425 (Pubitemid 46825496)
7. Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., Gromada, J., Brozinick, J. T., Hawkins, E. D., Wroblewski, V. J., Li, D. S., Mehrbod, F., Jaskunas, S. R., and Shanafelt, A. B. (2005) FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627-1635 (Pubitemid 40814671)
8. Kharitonenkov, A., and Shanafelt, A. B. (2008) Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases. BioDrugs 22, 37-44 (Pubitemid 351158533)
9. Goetz, R., Beenken, A., Ibrahimi, O. A., Kalinina, J., Olsen, S. K., Eliseenkova, A. V., Xu, C., Neubert, T. A., Zhang, F., Linhardt, R. J., Yu, X., White, K. E., Inagaki, T., Kliewer, S. A., Yamamoto, M., Kurosu, H., Ogawa, Y., Kuro-o, M., Lanske, B., Razzaque, M. S., and Mohammadi, M. (2007) Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell. Biol. 27, 3417-3428 (Pubitemid 46685217)
10. Harmer, N. J., Pellegrini, L., Chirgadze, D., Fernandez-Recio, J., and Blundell, T. L. (2004) The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity. Biochemistry 43, 629-640 (Pubitemid 38114050)
11. Mohammadi, M., Olsen, S. K., and Ibrahimi, O. A. (2005) Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16, 107-137 (Pubitemid 40616111)
12. Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., Eliseenkova, A. V., Mohammadi, M., and Kuro-o, M. (2007) βKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl. Acad. Sci. U.S.A. 104, 7432-7437 (Pubitemid 47185923)
13. Suzuki, M., Uehara, Y., Motomura-Matsuzaka, K., Oki, J., Koyama, Y., Kimura, M., Asada, M., Komi-Kuramochi, A., Oka, S., and Imamura, T. (2008) βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol. Endocrinol. 22, 1006-1014 (Pubitemid 351482834)
14. Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., and Kuro-o, M. (2007) Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282, 26687-26695 (Pubitemid 47501965)
15. Ito, S., Kinoshita, S., Shiraishi, N., Nakagawa, S., Sekine, S., Fujimori, T., and Nabeshima, Y. I. (2000) Molecular cloning and expression analyses of mouse βklotho, which encodes a novel Klotho family protein. Mech Dev. 98, 115-119
16. Kharitonenkov, A., Dunbar, J. D., Bina, H. A., Bright, S., Moyers, J. S., Zhang, C., Ding, L., Micanovic, R., Mehrbod, S. F., Knierman, M. D., Hale, J. E., Coskun, T., and Shanafelt, A. B. (2008) FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho. J. Cell Physiol. 215, 1-7 (Pubitemid 351363185)
17. Kharitonenkov, A., and Shanafelt, A. B. (2009) FGF21: a novel prospect for the treatment of metabolic diseases. Curr. Opin. Investig. Drugs 10, 359-364
18. Yie, J., Hecht, R., Patel, J., Stevens, J., Wang, W., Hawkins, N., Steavenson, S., Smith, S., Winters, D., Fisher, S., Cai, L., Belouski, E., Chen, C., Michaels, M. L., Li, Y. S., Lindberg, R., Wang, M., Véniant, M., and Xu, J. (2009) FGF21 N and C termini play different roles in receptor interaction and activation. FEBS Lett. 583, 19-24
19. Reits, E. A., and Neefjes, J. J. (2001) From fixed to FRAP: measuring protein mobility and activity in living cells. Nat. Cell Biol. 3, E145-147 (Pubitemid 32536847)
20. Digman, M. A., Dalal, R., Horwitz, A. F., and Gratton, E. (2008) Mapping the number of molecules and brightness in the laser scanning microscope. Biophys. J. 94, 2320-2332
21. Nagy, P., Claus, J., Jovin, T. M., and Arndt-Jovin, D. J. (2010) Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis. Proc. Natl. Acad. Sci. U.S.A. 107, 16524-16529
22. Kilkenny, D. M., and Rocheleau, J. V. (2008) Fibroblast growth factor receptor-1 signaling in pancreatic islet β-cells is modulated by the extracellular matrix. Mol. Endocrinol. 22, 196-205
23. Kircheis, R., Kichler, A., Wallner, G., Kursa, M., Ogris, M., Felzmann, T., Buchberger, M., and Wagner, E. (1997) Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4, 409-418 (Pubitemid 27226583)
24. Dalal, R. B., Digman, M. A., Horwitz, A. F., Vetri, V., and Gratton, E. (2008) Determination of particle number and brightness using a laser scanning confocal microscope operating in the analog mode. Microsc. Res. Tech. 71, 69-81
25. Ossato, G., Digman, M. A., Aiken, C., Lukacsovich, T., Marsh, J. L., and Gratton, E. (2010) A two-step path to inclusion formation of huntingtin peptides revealed by number and brightness analysis. Biophys. J. 98, 3078-3085
26. Brewer, C. F., Miceli, M. C., and Baum, L. G. (2002) Clusters, bundles, arrays, and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr. Opin. Struct. Biol. 12, 616-623 (Pubitemid 35449069)
27. Lajoie, P., Partridge, E. A., Guay, G., Goetz, J. G., Pawling, J., Lagana, A., Joshi, B., Dennis, J. W., and Nabi, I. R. (2007) Plasma membrane domain organization regulates EGFR signaling in tumor cells. J. Cell Biol. 179, 341-356 (Pubitemid 350004897)
28. Partridge, E. A., Le Roy, C., Di Guglielmo, G. M., Pawling, J., Cheung, P., Granovsky, M., Nabi, I. R., Wrana, J. L., and Dennis, J. W. (2004) Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306, 120-124 (Pubitemid 39451953)
29. Lau, K. S., Partridge, E. A., Grigorian, A., Silvescu, C. I., Reinhold, V. N., Demetriou, M., and Dennis, J. W. (2007) Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129, 123-134 (Pubitemid 46507588)
30. Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M. C., Moe, O. W., and Kuro-o, M. (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. 281, 6120-6123 (Pubitemid 43847540)
31. Nakamura, M., Uehara, Y., Asada, M., Honda, E., Nagai, N., Kimata, K., Suzuki, M., and Imamura, T. (2011) Sulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and βKlotho. J. Biol. Chem. 286, 26418-26423
32. Garner, O. B., and Baum, L. G. (2008) Galectin-glycan lattices regulate cell surface glycoprotein organization and signaling. Biochem. Soc Trans 36, 1472-1477
33. Chang, Q., Hoefs, S., van der Kemp, A. W., Topala, C. N., Bindels, R. J., and Hoenderop, J. G. (2005) The β-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310, 490-493 (Pubitemid 41507962)
34. Wang, F., Kan, M., McKeehan, K., Jang, J. H., Feng, S., and McKeehan, W. L. (1997) A homeo-interaction sequence in the ectodomain of the fibroblast growth factor receptor. J. Biol. Chem. 272, 23887-23895 (Pubitemid 27410970)
35. Lemmon, M. A., and Schlessinger, J. (2010) Cell signaling by receptor tyrosine kinases. Cell 141, 1117-1134
36. Beenken, A., and Mohammadi, M. (2009) The FGF family: biology, pathophysiology, and therapy. Nat. Rev. Drug Discov. 8, 235-253
37. Schlessinger, J., Plotnikov, A. N., Ibrahimi, O. A., Eliseenkova, A. V., Yeh, B. K., Yayon, A., Linhardt, R. J., and Mohammadi, M. (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6, 743-750
38. Goodger, S. J., Robinson, C. J., Murphy, K. J., Gasiunas, N., Harmer, N. J., Blundell, T. L., Pye, D. A., and Gallagher, J. T. (2008) Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms. J. Biol. Chem. 283, 13001-13008
39. Pellegrini, L., Burke, D. F., von Delft, F., Mulloy, B., and Blundell, T. L. (2000) Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407, 1029-1034